Portal hypertensive gastropathy and gastric antral vascular ectasia

Samuel Han, Nabeel Chaudhary, Wahid Wassef

Research output: Contribution to journalReview articlepeer-review

5 Scopus citations


Purpose of review Portal hypertensive gastropathy (PHG) and gastric antral vascular ectasia (GAVE) are two types of upper gastrointestinal bleeding that may present similarly, but are managed very differently. This article reviews the pathogenesis and guidelines in management of both of these conditions with emphasis on recent advances in the field. Recent findings Off-label use of Hemospray has been shown in several case series to be useful in managing acute bleeding from PHG. Balloon-occluded retrograde transvenous obliteration presents an alternative approach for this condition. Radiofrequency ablation may be an alternative therapy to argon plasma coagulation in the endoscopic treatment of GAVE, as it consists of fewer sessions and has been shown to decrease gastrointestinal blood loss. Summary The treatment options for PHG and GAVE are constantly evolving and expanding. In this review, we present the latest approaches in the gastroenterologist's arsenal to deal with these conditions.

Original languageEnglish (US)
Pages (from-to)506-512
Number of pages7
JournalCurrent Opinion in Gastroenterology
Issue number6
StatePublished - 2015
Externally publishedYes


  • Balloon-occluded retrograde transvenous obliteration
  • Hemospray
  • Radiofrequency ablation

ASJC Scopus subject areas

  • Gastroenterology


Dive into the research topics of 'Portal hypertensive gastropathy and gastric antral vascular ectasia'. Together they form a unique fingerprint.

Cite this